Related Experiment Video
Updated: Aug 27, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
Role of microRNAs in type 2 diseases and allergen-specific immunotherapy
Constanze A Jakwerth1, Hannah Kitzberger1, Dimitrii Pogorelov1
1Center of Allergy / Environment (ZAUM), Technical University of Munich, School of Medicine and Helmholtz Center Munich, German Research Center for Environmental Health, Member of the German Center for Lung Research (DZL), Member of the Immunology and Inflammation Initiative of the Helmholtz Association, Munich, Germany.
Abstract:
MicroRNAs (miRs) have gained scientific attention due to their importance in the pathophysiology of allergic diseases as well as their potential as biomarkers in allergen-specific treatment options. Their function as post-transcriptional regulators, controlling various cellular processes, is of high importance since any single miR can target multiple mRNAs, often within the same signalling pathway. MiRs can alter dysregulated expression of certain cellular responses and contribute to or cause, but in some cases prevent or repress, the development of various diseases. In this review article, we describe current research on the role of specific miRs in regulating immune responses in epithelial cells and specialized immune cells in response to various stimuli, in allergic diseases, and regulation in the therapeutic approach of allergen-specific immunotherapy (AIT). Despite the fact that AIT has been used successfully as a causative treatment option since more than a century, very little is known about the mechanisms of regulation and its connections with microRNAs. In order to fill this gap, this review aims to provide an overview of the current knowledge.
Insights
MicroRNAs (miRs) are key regulators in allergic diseases and potential biomarkers for allergen-specific immunotherapy (AIT). This review explores their role in immune responses and therapeutic mechanisms.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRs) are critical post-transcriptional regulators involved in cellular processes.
- Dysregulated miR expression contributes to the pathophysiology of various diseases, including allergic conditions.
- MiRs hold potential as biomarkers for diagnosing and treating allergic diseases.
Purpose of the Study:
- To review current research on the role of specific miRs in immune responses.
- To explore miR regulation in allergic diseases.
- To elucidate the connection between miRs and allergen-specific immunotherapy (AIT) mechanisms.
Main Methods:
- Literature review of current research on microRNAs in allergic diseases and immunotherapy.
- Analysis of miR function in epithelial and immune cells.
- Examination of miR involvement in immune response regulation.
Main Results:
- Specific miRs play significant roles in regulating immune responses in epithelial and immune cells.
- MiRs are implicated in the development and progression of allergic diseases.
- Understanding miR mechanisms is crucial for advancing allergen-specific immunotherapy.
Conclusions:
- MicroRNAs are integral to the immune system's response in allergic diseases.
- Further research into miRs can uncover novel therapeutic targets for AIT.
- This review highlights the current knowledge gaps and future directions in miR research for allergy treatment.
Related Concept Videos
Allergic Reactions
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Allergic Drug Reactions
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

